Design
Review
Key result
CaMKII has emerged as a key signaling molecule in the heart, and its inhibition represents a promising therapeutic target for preventing heart failure progression and arrhythmias.
Authors
Loading...
CaMKII inhibition merits targeted development; leaves open whether it improves outcomes in heart failure or arrhythmias.
Grandi et al. (2014) conducted an editorial in Heart failure, arrhythmia, myocardial hypertrophy. CaMKII inhibition was evaluated. CaMKII has emerged as a key signaling molecule in the heart, and its inhibition represents a promising therapeutic target for preventing heart failure progression and arrhythmias.